Jichen Yu

Investment Banking Analyst at CEC Capital
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Beijing, China, CN
Languages
  • English Full professional proficiency
  • Chinese Native or bilingual proficiency
  • Japanese Limited working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Certification of Completion
    Bloomberg LP
    Mar, 2020
    - Nov, 2024

Experience

  • CEC Capital
    • China
    • Investment Banking
    • 1 - 100 Employee
    • Investment Banking Analyst
      • Aug 2023 - Present

      • Constructed the equity valuation model including Financial Statement Forecast, DCF, Depreciation for a pharmaceutical equipment manufacture company to finance over $200 Million from investors • Generated market research on the company's flagship products-medical filler and drafted a business plan that highlights the company's strengths and industry insights to investors • Constructed the equity valuation model including Financial Statement Forecast, DCF, Depreciation for a pharmaceutical equipment manufacture company to finance over $200 Million from investors • Generated market research on the company's flagship products-medical filler and drafted a business plan that highlights the company's strengths and industry insights to investors

  • 长城证券
    • China
    • Investment Banking
    • 1 - 100 Employee
    • Investment Analyst
      • Jun 2023 - Jul 2023

      • Evaluated the Weight-loss drug market size in China of over $3B, identified high-potential biopharmaceutical firms, and provided investment advice for institutional investors on Antibody Fusion Protein Medications based on clinical data • Performed industry research on oncology drugs and new treatment method combining Antibody-Drug-Conjugates(ADC) drugs and immunotherapy(IO) which reaching historical high Overall Response Rate and Percent Free Survival rate • Researched Daiichi Sankyo's hotspot ADC drug DS-8201 Enhertu to cure Breast Cancer, and summarized China's leading pharmaceutical firms' ADC-IO products on sales and on experiments Show less

  • Leaf Group of NY
    • United States
    • Holding Companies
    • 1 - 100 Employee
    • Financial Analyst
      • Dec 2022 - May 2023

      • Prepared financial analysis and develop 20+ equity valuations based on DCF analysis for prospective investment across various industries, delivered cashflow forecast and appraised rate of return for team • Conducted and visualize 20+ cost structure analysis through comparing industry average from IBISWorld to evaluate firm's comparative advantage and built LBO model to appraise acquisition price ranging from $3M to $30M • Analyzed a 3D printing company by generating an equity valuation of $9.7M, proposed cost optimization solutions, presented promising prospects and highlighted company's strengths and weaknesses • Selected as only separate intern to facilitate coordination of merger and acquisition operations across different teams due to proactive attitude, diligence and proficiency in equity valuation • Developed a quick and new WACC calculation method, collecting cost of equity by industry on NYU Stern research website and estimate cost of debt by D/V ratio, sat up Excel template and introduced to team members Show less

  • Deloitte
    • Business Consulting and Services
    • 700 & Above Employee
    • Audit Assistant
      • Feb 2021 - Mar 2021

      • Performed 10+ financial statement analysis on listed real-estate companies' by calculating indicators including ROE, Current Ratios, and Debt to Equity Ratio, envisioned yearly trends using Excel, and summarized current financial position • Proceeded third-party due diligence investigation for several real-estate companies by classifying positive and negative news and denoted accordingly market reflections into Excel • Cooperated with team members to input invoices, validated invoices and highlighted missing invoices through China Bureau of Taxation website separately to increase efficiency, and integrated final results into Excel Show less

Education

  • Columbia University
    Master's degree, Enterprise Risk Management
  • University of Rochester
    Bachelor's degree, Finance, General
  • Northeastern University
    Business Administration and Management, General, 3.72/4.0
    2019 - 2021
  • Beijing No.4 High School
    High School Diploma, Alumni

Community

You need to have a working account to view this content. Click here to join now